Pilot to Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Cancer
Misako Nagasaka
A Pilot Study to Assess the Diversity of Gut Microbiome in Metastatic Non-Small Cell Lung Cancer (NSCLC) in Correlation to Treatment Effects and Adverse Effects
Lung

Study Description

The purpose of this research study is to investigate the makeup of gut microbiome that occurs during the course of treatment for non-small cell lung cancer (NSCLC).

Eligibility

You can participate in this study if you

• Are 18 years of age or older

• Able to provide written informed consent

• Have advanced/metastatic non-small cell lung cancer

You cannot participate in this study if you

 Are clinically unstable and need to focus on your treatment.

A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.